Curative Effect of EGFR-TKIs with Anti-angiogenic Drugs as the Treatment for Patients with Advanced EGFR-mutant Non-small Cell Lung Cancer：a Meta-analysis

Curative Effect of EGFR-TKIs with Anti-angiogenic Drugs as the Treatment for Patients with Advanced EGFR-mutant Non-small Cell Lung Cancer：a Meta-analysis

BackgroundAcquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) will eventually occur in almost all advanced EGFR-mutant non-small cell lung cancer (EGFR-mutant NSCLC) patients although the therapy has been a standard treatment for such patients. But EGFR-TKI...

Full description

Bibliographic Details
Main Author: LI Yong, LONG Yong, ZHAO Chong, ZHANG Guanqing, SU Yanhe
Format: Article
Language:zho
Published: Chinese General Practice Publishing House Co., Ltd 2022-03-01
Series:Zhongguo quanke yixue
Subjects:
|carcinoma, non-small-cell lung|angiogenesis inhibitors|epidermal growth factor receptor tyrosine kinase inhibitors|efficacy|meta-analysis
Online Access:https://www.chinagp.net/fileup/1007-9572/PDF/yx2021123102.pdf

Internet

https://www.chinagp.net/fileup/1007-9572/PDF/yx2021123102.pdf

Similar Items